Human monoclonal antibodies to hiv-1 mn gp 120
CA 2058630 A1 · Owner: Rusche, James R. · Inventors: White-Scharf, Mary E.; Rusche, James R.; Carson, Helen F.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An antibody capable of neutralizing the MN prototype of HIV or an MN variant virus thereof, wherein an amino acid sequence within the principal neutralizing domain of the MN prototype comprises the sub-sequence, at positions A1-A17 of the principal neutralizing domain, of amino acid residues K-R-K-R-I-H-I-G-P-G-R-A-F-Y-T-T-K, and the corresponding amino acid sub-sequence of the MN variant includes a completely homologous sequence at the I-G-P-G-R residues at positions A7-A11 and at least 36 % homology over the remaining residues of the MN prototype sub-sequence.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 5, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.